Literature DB >> 17245406

The complexity of reproductive decision-making in asymptomatic carriers of the Huntington mutation.

Marleen Decruyenaere1, Gerry Evers-Kiebooms, Andrea Boogaerts, Kristien Philippe, Koen Demyttenaere, René Dom, Wim Vandenberghe, Jean-Pierre Fryns.   

Abstract

The aim of this study was to describe reproductive decisions in mutation carriers after predictive testing for Huntington's disease (HD) and to identify factors that play a role in decision-making. In 1987-2004, 245 individuals received a predictive test result; 89 of them were carriers and seven received an equivocal result. Quantitative data on reproductive behaviour have been collected during all follow-up contacts. The follow-up time in this study was 1-16 years (mean: 7.1 years). Qualitative data on reproductive decision-making have been collected by the means of semistructured interviews during the 5-year follow-up study. For 46 carriers and two persons with an equivocal result, family planning was one of the motives for predictive testing. In this group, slightly more than half of the carriers (58%) had chosen to have children with prenatal diagnosis or preimplantation genetic diagnosis and about one in three (35%) decided to have no children anymore after the test. A minority (7%) was undecided or had no children for other reasons. Factors playing a role in the decision-making process were the carrier's sex, ethical issues about PD and PGD, the strength of the desire to have children, illness representations including personal experiences with HD in the family and the technological imperative. Some of these elements were in conflict and induced ambivalence towards reproductive choices. The results illustrate the complexity of the decision-making process and the necessity of in-depth counselling. Counselling should pay special attention to conflicting values and beliefs and to all kinds of pressure.

Entities:  

Mesh:

Year:  2007        PMID: 17245406     DOI: 10.1038/sj.ejhg.5201774

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  26 in total

1.  Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres.

Authors:  Maartje C Van Rij; Marjan De Rademaeker; Céline Moutou; Jos C F M Dreesen; Martine De Rycke; Inge Liebaers; Joep P M Geraedts; Christine E M De Die-Smulders; Stéphane Viville
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  What were you thinking?: individuals at risk for Huntington Disease talk about having children.

Authors:  Kimberly A Quaid; Melinda M Swenson; Sharon L Sims; Joan M Harrison; Carol Moskowitz; Nonna Stepanov; Gregory W Suter; Beryl J Westphal
Journal:  J Genet Couns       Date:  2010-08-24       Impact factor: 2.537

3.  Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Authors:  Janet K Williams; Cheryl Erwin; Andrew Juhl; James Mills; Bradley Brossman; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2010-08-19

4.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

5.  Impact of Huntington Disease Gene-Positive Status on Pre-Symptomatic Young Adults and Recommendations for Genetic Counselors.

Authors:  Ping Gong; Joanna H Fanos; Lauren Korty; Carly E Siskind; Andrea K Hanson-Kahn
Journal:  J Genet Couns       Date:  2016-04-22       Impact factor: 2.537

Review 6.  A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.

Authors:  Felicity Wadrup; Simon Holden; Rhona MacLeod; Zosia Miedzybrodzka; Andrea H Németh; Shan Owens; Sara Pasalodos; Oliver Quarrell; Angus J Clarke
Journal:  Eur J Hum Genet       Date:  2019-03-19       Impact factor: 4.246

7.  Reproductive decision making: interviews with mothers of children with undiagnosed developmental delay.

Authors:  Emily Pond; Rebecca Dimond
Journal:  J Community Genet       Date:  2018-02-01

8.  Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience.

Authors:  Tania Cruz-Mariño; Luis Velázquez-Pérez; Yanetza González-Zaldivar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Yaimé Vázquez-Mojena; Annelié Estupiñán-Rodríguez; Rubén Reynaldo-Armiñán; Luis Enrique Almaguer-Mederos; José Miguel Laffita-Mesa; Victor Tamayo-Chiang; Milena Paneque
Journal:  J Community Genet       Date:  2013-05-15

9.  "To perpetuate blindness!": attitudes of UK patients with inherited retinal disease towards genetic testing.

Authors:  Barbara Potrata; Martin McKibbin; Jennifer Nw Lim; Jenny Hewison
Journal:  J Community Genet       Date:  2013-12-24

10.  Attitude towards pre-implantation genetic diagnosis for hereditary cancer.

Authors:  Chantal Lammens; Eveline Bleiker; Neil Aaronson; Annette Vriends; Margreet Ausems; Maaike Jansweijer; Anja Wagner; Rolf Sijmons; Ans van den Ouweland; Rob van der Luijt; Liesbeth Spruijt; Encarna Gómez García; Mariëlle Ruijs; Senno Verhoef
Journal:  Fam Cancer       Date:  2009-07-30       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.